Trial · NCT06052930
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline to 6-week in TUG cognitive test | 6 week | Change from baseline to 6-week in TUG cognitive test |
| Secondary | Change from baseline to each evaluation time point in TUG and TUG with motor and cognitive dual-tasking | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in TUG and TUG with motor and cognitive dual-tasking |
| Secondary | Change from baseline to each evaluation time point in MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in MDS-UPDRS |
| Secondary | Change from baseline to each evaluation time point in mini-Balance Evaluation Systems Test (mini-BEST test) | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in mini-BEST test |
| Secondary | Change from baseline to each evaluation time point in Montreal Cognitive Assessment (MoCA) | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in MoCA |
| Secondary | Change from baseline to each evaluation time point in Stroop test | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in Stroop test |
| Secondary | Change from baseline to each evaluation time point in Visual Object and Space Perception (VOSP) Battery (cube and fragmented letters) | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in VOSP-cube analysis and VOSP-fragmented letters |
| Secondary | Change from baseline to each evaluation time point in Parkinson's Disease Questionnaire-39 items (PDQ-39) | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in PDQ-39 score |
| Secondary | Change from baseline to each evaluation time point in Schwab and England (S&E) scale | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in S\&E scale |
| Secondary | Change from baseline to each evaluation time point in Clinical and Patient Global Impression of severity | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in Clinical and Patient Global Impression of severity |
| Secondary | Change from baseline to each evaluation time point in BMI | 6, 12 and 16 weeks | Difference between groups in change from baseline to each evaluation time point in BMI |
| Secondary | Occurrence of adverse events | 16 weeks | Difference between groups in patient's safety |
| Secondary | Occurrence of cybersickness using the Simulator Sickness Questionnaire (SSQ) | 16 weeks | Difference between groups in SSQ |
| Secondary | Patients' consideration on system usability using the System Usability Scale (SUS) | 1, 6, 12 and 16 weeks | SUS after the 1st week using the IVR system and at each evaluation time point |
| Secondary | Patients' Borg perceived exertion | 16 weeks | Difference between groups in perceived exertion |
| Secondary | Likert scale on patients' satisfaction using the virtual reality system | 12 weeks | Difference between groups in patients' satisfaction |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06052930/registered